Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.1
21.54%
60%
—
-28.70%
20%
—
5 Years
Score4.1
Net Growth21.54%
Net Trend60%
Net Income Consistency—
Rev Growth-28.70%
Rev Trend20%
Revenue Consistency—
Enanta Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 122M to $ 65M and net income went from -$ 36M to -$ 81M. Revenue increased in 1 of those 5 years; net income in 3.
Between 2015 and 2025, revenue declined from $ 160M to $ 65M and net income went from $ 78M to -$ 81M. Revenue increased in 3 of those 10 years; net income in 4.
Enanta Pharmaceuticals Inc currently holds a 5-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 13.50 | — |
1 Year2025-08-12 | $ 6.86 | 96.79% |
5 Years2021-08-12 | $ 46.18 | -70.77% |
10 Years2016-08-12 | $ 23.41 | -42.33% |
All Time2013-03-21 | $ 17.18 | -21.42% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2013-03-21 |
|---|---|---|---|---|---|
| Price | $ 13.50 | $ 6.86 | $ 46.18 | $ 23.41 | $ 17.18 |
| Return | — | 96.79% | -70.77% | -42.33% | -21.42% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 69M | -$ 61M | $ 163M |
| 2025 | $ 65M | -$ 81M | $ 188M |
| 2024 | $ 67M | -$ 116M | $ 248M |
| 2023 | $ 79M | -$ 133M | $ 369M |
| 2022 | $ 86M | -$ 121M | $ 249M |
| 2021 | $ 97M | -$ 78M | $ 244M |
| 2020 | $ 122M | -$ 36M | $ 386M |
| 2019 | $ 205M | $ 46M | $ 335M |
| 2018 | $ 206M | $ 71M | $ 308M |
| 2017 | $ 102M | $ 17M | $ 223M |
| 2016 | $ 88M | $ 21M | $ 210M |
| 2015 | $ 160M | $ 78M | $ 145M |
| 2014 | $ 47M | $ 34M | $ 90M |
| IPO2013 | $ 32M | $ 9M | $ 101M |
Explore beyond ENTA
You're looking at Enanta Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
